p63 as a prognostic marker for giant cell tumor of bone

References

• Persson BM, Ekelund L, Lövdahl R, Gunterberg B. Favourable results of acrylic cementation for giant cell tumors. Acta Orthop Scand. 1984;55:209–14.
   PubMed Web of Science ®Google Scholar
• Capanna R, Fabbiri N, Bettelli G. Currettage of giant cell tumor of bone: the effect of surgical technique and adjuvants on local recurrence rate. Chir Organi Mov. 1990;75:206.
   PubMedGoogle Scholar
• Szendöi M, Kiss J, Antal I. Surgical treatment and prognostic referrals in giant-cell tumor of bone. Acta Chir Orthop Traumatol Chech. 2003;70:142–50.
   PubMedGoogle Scholar
• Dickson B, Li S, Wunder J, Ferguson P, Eslami B, Werier J, Giant cell tumor of bone express p63. Mod Pathol. 2008;21:369–75.
   PubMed Web of Science ®Google Scholar
• Lee C, Espinosa I, Jensen K, Subramanian S, Zhu S, Varma S, Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone. Mod Pathol. 2008;21:531–9.
   PubMed Web of Science ®Google Scholar
• de la Roza G. p63 expression in giant cell-containing lesion of bone and soft tissue. Arch Pathol Lab Med. 2010;135:776–9.
   Web of Science ®Google Scholar
• Yanagisawa M, Okada K, Tajino T, Tirugoe T, Kawai A, Nishida J, Clinicopathological study of giant cell tumor of small bones. Upsala J Med Sci. 2011;116:265–8.
   PubMed Web of Science ®Google Scholar
• Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS. Treatment of giant cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg Am. 1999;81:811–20.
   PubMedGoogle Scholar
• Nakajima H, Arai T, Shimizu K, Beppu M, Takagi M, Kazama A. Intra-lesional excision with local adjuvant treatment utilizing phenol cauterization for giant cell tumor of bone. Rinsho Seikei Geka. 2006;41:1093–8.
   Google Scholar
• Malawer M, Bickels J, Meller I, Buch R, Henshaw R, Kollender Y. Cryosurgery in the treatment of giant cell tumor. Clin Orthop. 1999;359:176–88.
   Google Scholar
• Zhen W, Yaortian H, Songjian L, Ge L, Qingliang W. Giant-cell tumor of bone. J Bone Joint Surg Br. 2004;86:212–16.
   PubMedGoogle Scholar
• O’Donnell R, Springfield D, Motowani H, Ready J, Gebhardt M, Mankin H. Recurrence of giant-cell tumors of long bones after curettage and packing with cement. J Bone Joint Surg Am. 1994;76:1827–33.
   PubMed Web of Science ®Google Scholar
• Remedios D, Saifuddin A, Pringle J. Radiological and clinical recurrence of giant-cell tumor of bone after the use of cement. J Bone Joint Surg Br. 1997;79:26–30.
   PubMedGoogle Scholar
• Wada T, Kaya M, Nagoya S, Kawaguchi S, Isu K, Yamashita T, Complications associated with bone cementing for the treatment of giant cell tumor of bone. J Orthop Sci. 2002;7:194–8.
   PubMedGoogle Scholar
• Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69:106–4.
   PubMed Web of Science ®Google Scholar
• Su Y, Chen W, Chen T. Giant-cell tumors of bone: an analysis of 87 cases. Int Orthop. 2004;28:239–43.
   PubMed Web of Science ®Google Scholar
• Gitelis S, Mallin BA, Piasecki P, Turner F. Intralesional excision compared with en block resection for giant-cell tumors of bone. J Bone Joint Surg Am. 1993;75:1648–55.
   PubMedGoogle Scholar
• McDonald D, Sim F, McLeod R, Dahlin D. Giant-cell tumor of bone. J Bone Joint Surg Am. 1986;68:235–42.
   PubMed Web of Science ®Google Scholar
• Unni KK, Inward CY. Bone tumors. 6th ed. New York: Lippincott-Raven; 2010.
   Google Scholar
• Alberghini M, Kliskey K, Krenacs T, Picci P, Kindblom L, Forsyth R, Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone. Virchows Arch. 2010;456:97–103.
   PubMed Web of Science ®Google Scholar
• Wülling M, Engels C, Jesse N, Werner M, Delling G, Kaiser E. The nature of giant cell tumor of bone. J Cancer Res Clin Oncol. 2001;127:467–74.
   PubMed Web of Science ®Google Scholar
• Wülling M, Delling G, Kaiser E. The origin of the neoplastic stromal cell in giant cell tumor of bone. Hum Pathol. 2003;34:983–93.
   PubMed Web of Science ®Google Scholar
• Mills A. p63: oncogene or tumor suppressor? Curr Opin Genet Dev. 2006;16:38–44.
   PubMed Web of Science ®Google Scholar
• Como C, Urist M, Babayan I, Drobnjak M, Hedvat C, Teruya-Feldstein J, p63 expression profiles in human normal and tumor tissues. Clin Cancer Res. 2002;8:494–501.
   PubMed Web of Science ®Google Scholar
• Geddert H, Kiel S, Heep H, Gabbert H, Sarbia M. The role of p63 and ΔNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis. Hum Pathol. 2003;34:850–6.
   PubMed Web of Science ®Google Scholar
• Koga F, Kawakami A, Fujii Y, Saito K, Ohtsuka Y, Iwai A, Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res. 2003;9:5501–7.
   PubMed Web of Science ®Google Scholar